These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19137749)

  • 41. What happened to the Provenge (Sipuleucel-T) vaccine for hormone refractory prostate cancer?
    Moyad MA
    Urol Nurs; 2007 Jun; 27(3):256-7. PubMed ID: 17674606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New therapies for castration-resistant prostate cancer.
    Longo DL
    N Engl J Med; 2010 Jul; 363(5):479-81. PubMed ID: 20818868
    [No Abstract]   [Full Text] [Related]  

  • 43. Death threats for discrepancies over treatment data.
    Burton A
    Lancet Oncol; 2007 Jul; 8(7):577. PubMed ID: 17668482
    [No Abstract]   [Full Text] [Related]  

  • 44. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

  • 45. PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
    Cheever MA; Higano CS
    Clin Cancer Res; 2011 Jun; 17(11):3520-6. PubMed ID: 21471425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is Provenge Angst a symbol or symptom of the times?
    Holcombe DG
    Am J Manag Care; 2012 May; 18(3 Spec No.):SP108-9. PubMed ID: 22642274
    [No Abstract]   [Full Text] [Related]  

  • 47. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 48. Immune-boosting prostate cancer vaccine endorsed by FDA advisors.
    McBride D
    ONS Connect; 2007 Jul; 22(7):19. PubMed ID: 17694780
    [No Abstract]   [Full Text] [Related]  

  • 49. Provenge: combating prostate cancer with a vengeance?
    Schwaab T; Pili R
    Expert Rev Vaccines; 2011 Aug; 10(8):1113-4. PubMed ID: 21854304
    [No Abstract]   [Full Text] [Related]  

  • 50. Business barriers slowing the pace of cancer immunotherapy research and development.
    Tuma RS
    J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer.
    Sims RB
    Vaccine; 2012 Jun; 30(29):4394-7. PubMed ID: 22122856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA.
    Hovden AO; Appel S
    Scand J Immunol; 2010 Dec; 72(6):554. PubMed ID: 21044130
    [No Abstract]   [Full Text] [Related]  

  • 53. Therapy: An immune one-two punch.
    Bourzac K
    Nature; 2015 Dec; 528(7582):S134-6. PubMed ID: 26672788
    [No Abstract]   [Full Text] [Related]  

  • 54. Project Zero Delay: a process for accelerating the activation of cancer clinical trials.
    Kurzrock R; Pilat S; Bartolazzi M; Sanders D; Van Wart Hood J; Tucker SD; Webster K; Mallamaci MA; Strand S; Babcock E; Bast RC
    J Clin Oncol; 2009 Sep; 27(26):4433-40. PubMed ID: 19652061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TransMolecular receives FDA approval for 131-I-TM-601 IND application.
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):139. PubMed ID: 12113233
    [No Abstract]   [Full Text] [Related]  

  • 56. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW
    New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial comment.
    Drake C
    Urology; 2013 Jun; 81(6):1302. PubMed ID: 23582480
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent developments in health law. Administrative law v. constitutional law: the correct decision on FDA's treatment of Plan B.
    Shachar C
    J Law Med Ethics; 2009; 37(3):523-7. PubMed ID: 19723264
    [No Abstract]   [Full Text] [Related]  

  • 59. Prostate cancer.
    Brody H
    Nature; 2015 Dec; 528(7582):S117. PubMed ID: 26672779
    [No Abstract]   [Full Text] [Related]  

  • 60. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.